V

Vaxcyte

Develops broad-spectrum vaccines for bacterial infections

Stability Manager

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSan Carlos, CA, USAIn-person

About the Job

Requirements

  • A master's or bachelor's degree and at least 8 years of industry experience in the pharmaceutical or biotechnology industry; other combinations of education and/or experience may be considered.
  • Strong understanding of vaccine stability principles, including degradation pathways, accelerated stability testing, and shelf-life determination.
  • Demonstrated proficiency and expertise in analytical methodologies, particularly for stability testing and assessment of biologics or vaccines.
  • Understanding of relevant FDA, EU, and ICH regulatory guidelines and pharmacopeia applicable to stability study design, expiry dating, and analytical method qualification and validation for biologics and vaccines.
  • Hands-on experience applying basic statistical tools for stability data trending and rate analysis to support retest-period and shelf-life proposals.
  • Attention to detail and skills in record keeping and documentation.
  • Experience working in a regulated GLP or GMP environment.
  • Extensive technical writing experience.
  • Understanding of product development activities in biotech, drug, or vaccine development, including key interdependencies and proven development strategies and tactics.
  • Ability to work globally with contract manufacturing organizations in different countries and continents.

Responsibilities

  • Design, coordinate, and execute stability studies for early- and late-stage vaccine products according to regulatory guidelines and company protocols.
  • Summarize vaccine stability results using analytical testing expertise and statistical software such as JMP to perform statistical analyses and interpret data in accordance with regulatory standards.
  • Create, implement, and manage stability databases; perform data trending and statistical analysis; forecast studies and testing; report metrics; and create, revise, and approve SOPs, stability protocols, and reports in accordance with current GMP, FDA, EU, global, and ICH guidelines and regulations.
  • Produce PowerPoint presentations to communicate stability data to project team members; support project milestones by facilitating stability monitoring and determining expiration dates for clinical and in-process materials.
  • Author, review, revise, and approve SOPs, stability protocols and reports, memoranda, regulatory documents, and specification documents as required.
  • Assist in leading the functionality and maintenance of stability-related processes and systems.
  • Drive continuous improvement activities for clinical stability programs.
  • Ensure the GMP stability program aligns with FDA, ICH, and other international agency requirements.
  • Manage QC Stability quality-system records, including creating, assessing, and reviewing deviations, change controls, CAPAs, and other applicable stability-related investigations and events.
  • Guide and work with others to identify continuous-improvement opportunities and implement and maintain solutions.
  • Help establish a quality culture and shared accountability; ensure GMP compliance is built into process and system design and implementation, including tracking metrics to monitor and improve performance.

Desired Qualifications

  • Experience in IND, NDA, and BLA submissions is highly preferred.
  • Strong interpersonal skills and the ability to communicate effectively verbally and in writing.

About the Company

Vaxcyte

Develops broad-spectrum vaccines for bacterial infections

Vaxcyte develops vaccines to prevent bacterial infections, focusing on broad-spectrum pneumococcal vaccines and other targets like Group A Strep, periodontitis, and Shigella. Its lead product, VAX-24, covers 24 Streptococcus pneumoniae strains and is produced using the XpressCF cell-free protein synthesis platform, which enables multi-strain conjugate vaccines. The company differentiates itself by combining cell-free manufacturing with broad strain coverage and has FDA Breakthrough Therapy designation for VAX-24, helping speed development. Its goal is to bring broadly protective bacterial vaccines to market, reduce serious infections worldwide, and expand its portfolio with products like VAX-31 and additional preclinical candidates.

Company size
501-1,000
Company stage
IPO
Headquarters
San Carlos, CA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Vaxcyte

See more jobs